Addressing changed sexual functioning in cancer patients: A cross-sectional survey among Dutch oncology nurses by Krouwel, E.M. et al.
lable at ScienceDirect
European Journal of Oncology Nursing xxx (2015) 1e9Contents lists avaiEuropean Journal of Oncology Nursing
journal homepage: www.elsevier .com/locate/ejonAddressing changed sexual functioning in cancer patients:
A cross-sectional survey among Dutch oncology nurses
E.M. Krouwel a, *, M.P.J. Nicolai a, A.Q.M.J. van Steijn-van Tol b, H. Putter c, S. Osanto b,
R.C.M. Pelger a, H.W. Elzevier a
a Department of Urology, Leiden University Medical Centre, PO Box 9600, 2300 WB Leiden, The Netherlands
b Department of Oncology, Leiden University Medical Centre, PO Box 9600, 2300 WB Leiden, The Netherlands







Attitude of health personnel
Questionnaires* Corresponding author. Leiden University Medical
ogy, J3P, PO Box 9600, 2300 WB Leiden, The Netherl
fax: þ31 71 5248135.
E-mail address: E.M.Krouwel@lumc.nl (E.M. Krouw
http://dx.doi.org/10.1016/j.ejon.2015.05.005
1462-3889/© 2015 Elsevier Ltd. All rights reserved.
Please cite this article in press as: Krouwel
among Dutch oncology nurses, European Joa b s t r a c t
Purpose: In most types of cancer, the disease and its treatment can result in altered sexual function (SF).
Oncology nurses are strategically placed to address SF since they have frequent patient interaction. Our
aim was to establish their knowledge about and attitudes to SF in oncology care and identify their
perceived barriers to addressing the subject.
Methods: A 37-item questionnaire was administered during the 2012 Dutch Oncology Nursing Congress
and mailed to 241 Dutch oncology nursing departments.
Results: The majority of 477 nurses (87.6%) agreed that discussing SF is their responsibility. Discussing SF
routinely is performed by 33.4% of these nurses, consultations mainly consisted of mentioning treatment
side-effects affecting SF (71.3%). There were significant differences depending on experience, knowledge,
age, academic degree and department policy. Nurses 44 years old (p < 0.001), with <10 years oncology
experience (p ¼ 0.001), insufficient knowledge (p < 0.001), no academic degree (p < 0.001), and in whose
department policy was lacking or inadequate (p < 0.001), were less comfortable discussing SF. Barriers
included lack of training, presence of a third party and no angle or motive for initiating discussion.
Conclusions: Findings suggest oncology nurses consider counselling on sexual issues to be an important
responsibility, in line with discussing other side-effects caused by the disease or its treatment. Never-
theless, cancer patients may not routinely be receiving a sexual health evaluation by oncology nurses.
Results emphasize the potential benefit of providing knowledge, including practical training and a
complete department protocol.
© 2015 Elsevier Ltd. All rights reserved.Introduction
For most types of cancer, regardless of the patient's age or
relationship status, the disease and its treatment can lead to a
deterioration in sexual health (Baker et al., 2005; Beckjord et al.,
2011; Den Oudsten et al., 2012; Galbraith and Crighton, 2008;
Hughes, 2008; Lange et al., 2009; Sadovsky et al., 2010; Wright
et al., 2002). The World Health Organisation has addressed sexual
health as an integral aspect of wellbeing, defined as ‘a state of
physical, emotional, mental and social well-being in relation toCentre, Department of Urol-
ands. Tel.: þ31 71 526 5255;
el).
, E.M., et al., Addressing chan
urnal of Oncology Nursing (2sexuality; it is not merely the absence of disease, dysfunction or
infirmity. Sexual health requires a positive and respectful approach
to sexuality and sexual relationships, as well as the possibility of
having pleasurable and safe sexual experiences, free of coercion,
discrimination and violence’ (World Health Organization, 2006).
Sexual health cannot be defined without considering sexuality,
partially defined as ‘a central aspect of being human throughout life
and encompasses sex, gender identities and roles, sexual orienta-
tion, eroticism, pleasure, intimacy and reproduction’ (World Health
Organization, 2006). Satisfactory sexual function (SF) (i.e. sexual
health despite the presence of disease) is considered to make an
important contribution to the quality of life of cancer patients
(Flynn et al., 2011; Krebs, 2008; Stead et al., 2003). The disease,
however, frequently interferes with SF, leading to sexual dysfunc-
tion (SD). With rising long-term survival-rates for cancer, quality of
life, including sexual health, is becoming increasingly significant.ged sexual functioning in cancer patients: A cross-sectional survey
015), http://dx.doi.org/10.1016/j.ejon.2015.05.005
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participate in intimate relationships and accordingly assimilate the
rehabilitation of self-esteem and physical body function.
Causes of a deterioration in SF in cancer patients are often
physically and mentally ambiguous. Surgery, chemotherapy, hor-
monal agents, radiation therapy, intrinsic disease and psychological
disease-related or body image factors may all contribute to a
decrease in SF. Despite the fact that it is considered important by
both patients and health professionals, patients and survivors have
indicated that SF is frequently not addressed by oncology health
care providers and an unmet need for information exists (Flynn
et al., 2012). According to multifarious studies, compromising
data on self-reported practice attitudes and observed practice at-
titudes, discussing SF with patients is not routinely performed by
multidisciplinary oncology health care providers (Flynn et al., 2012;
Gamel et al., 1995; Hautamaki et al., 2007; Hordern and Street,
2007; Julien et al., 2010; Kotronoulas et al., 2009; Lavin and Hyde,
2006; Nakopoulou et al., 2009; Olsson et al., 2012; Oskay et al.,
2014; Stead et al., 2003; White et al., 2011; Zeng et al., 2011).
Oncology nurses are in a strategic position to be able to address
SF, since they have frequent contact with patients when they can
providemedical and emotional support for issues of concern during
illness, treatment and recovery. Consequently, they are able to
identify changes and provide information about the effect of the
disease and its treatment on SF. The Oncology Nursing Society
(USA) stated in 1979 that sexual health is an integral aspect of
quality care in outcome standards for cancer nursing practice
(Valencius et al., 1980). The first Dutch national guideline on SF was
accepted by the Comprehensive Cancer Centre of the Netherlands
(IKNL) in 2006, describing the important position of the oncology
nurse in diagnosing and intervening in cancer-related SD (Integraal
Kankercentrum Nederland, 2006).
Although discussing SF is officially stated as an important
component of oncology nursing practice worldwide, many nurses
experience barriers in actually discussing psychological or physio-
logical aspects of SF. Barriers identified in previous publications
involved factors like incorrect assumptions regarding sexual issues,
discomfort, lack of knowledge (Kotronoulas et al., 2009), ‘it is not
my responsibility’, embarrassment (Stead et al., 2003), patients do
not expect nurses to discuss sexual concerns, confidence (Julien
et al., 2010), lack of training, difficult to bring up the subject and
lack of time (Hautamaki et al., 2007). Furthermore, it was shown
that cancer patients, who themselves had to initiate discussion
with an oncology professional about SF, already experienced
significantly greater SD than thosewho did not bring up the subject
(Flynn et al., 2012). The fact that routine nursing practice currently
neglects addressing SF is emphasized by patients who state that
more attention should be paid to SD (Hill et al., 2011; Hordern and
Street, 2007; Stead et al., 2003). While health care professionals do
little to address SF (Bekker et al., 2009, 2011; Nicolai et al., 2013;
Saunamaki et al., 2010), patients with all types of cancer are
willing to talk about their sex lives and the impact of the disease on
their SF (Ananth et al., 2003; Hill et al., 2011). For over thirty years,
international nursing and treatment guidelines have highlighted
the importance of discussing SF and providing additional infor-
mation. In their daily practice, however, nurses often avoid
responding or fail to respond to patients’ sexual concerns.
Considering the incidence, the influence on quality of life and the
patients’ need to discuss the impact of disease on SF, there is much
room for improvement in sexual health care provision in oncology
departments.
Our aim was to investigate nurses’ knowledge about and opin-
ions on the responsibility for addressing SF in oncology treatment
settings in The Netherlands, as well as looking at their attitudes to
the subject and identifying what they consider as barriers toPlease cite this article in press as: Krouwel, E.M., et al., Addressing chan
among Dutch oncology nurses, European Journal of Oncology Nursing (2addressing it. In addition, the possible wish of oncology nurses for
supplementary education and practical training in counselling on
sexual matters was investigated. Several previous studies have
recommended future research using a larger sample, in order to
have a more representative overview. Since conflicting findings
have been reported worldwide and as the studies performed have
been mostly qualitative, based on a single centre and relatively
small samples, we considered it essential to investigate the Dutch
nurses’ attitudes and practice behaviour in a nationwide quanti-
tative study design (Kotronoulas et al., 2009). We postulated that
most Dutch oncology nurses are aware of the possible impact of
cancer diagnosis and treatment on SF, but they do not routinely
take a sexual history because of difficulties in bringing the subject
up and stereotypical assumptions about sexuality in the face of
cancer. This study was performed as part of an extensive study on
possible omissions regarding attention paid to SF in oncology care,




Data for this cross-sectional survey were collected using a
questionnaire. The sample consisted of Dutch nurses involved with
oncology patients working in various departments in several clin-
ical settings. Our sampling strategy aimed to be representative with
regard to tumour site, employment setting, level of education, years
of oncology experience, type of hospital, age and gender.
Instrument design and development
The established Sexuality Attitudes and Beliefs Survey (SABS)
assesses nurses’ attitudes to and views on human sexuality with 12
items presented in a Likert-type format (1e6 levels of agreement)
(Reynolds and Magnan, 2005). In order to acquire extensive infor-
mation on all relevant factors covering the aim of this study, not
included in the SABS, it was decided to design a more compre-
hensive questionnaire. The current questionnaire design does,
however, comprise items addressed in the SABS. The 37-item
questionnaire was developed by the corresponding author
(E.M.K.) in cooperation with an expert-panel, consisting of an
experienced sexology researcher (M.P.J.N.), a urologistesexologist
(H.W.E.), a professor of oncology (S.O.) and an oncology research
nurse (A.Q.M.J.v.S) (Appendix 1). A literature reviewwas conducted
to find other surveys in the field of nursing and sexuality, in order to
merge all relevant items, barriers and what was not yet known. The
design made use of previous surveys among health care providers
(Bekker et al., 2011; Nicolai et al., 2013), studies which measured
adequately attitudes regarding sexuality. After the initial instru-
ment design, the authors individually scored all items for content
validity. Items scored as non-essential by multiple authors were
removed. The pilot questionnaire was reviewed by 10 anonymous
oncology nurses from the LUMC (Leiden University Medical Centre)
and modified using their feedback. In the pilot, the questionnaire
was tested for length, layout, linguistic inaccuracies, identification
of problematic questions, advice on content, whether response
choices were appropriate and whether respondents followed di-
rections. On the basis of the pilot, irrelevant questions were
removed and minor linguistic changes and question order modifi-
cations made.
The final version comprised a demographic sheet and Likert-
scale items (ranging from 1 to 5 levels of agreement) measuring
practices, attitudes, content of sexual counselling, responsibility,
need for education and barriers regarding discussing SF and fertilityged sexual functioning in cancer patients: A cross-sectional survey
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experience in oncology practice, gender and age. Internal and
external barriers, which, on the basis of literature, were assumed to
be present, included patients’ age, partnership, culture, language,
privacy, state of disease, prognosis and other possible restraints. All
results were compared, taking into account demographic respon-
dent information which might be relevant, such as age, gender,
experience and knowledge. We also investigated the existence of
local protocols and perceptions concerning the responsibility for
addressing SF, in order to clarify whether or not this is indeed a
nursing responsibility. All responses were processed anonymously.
Questionnaires were included for analysis when the participant
had completed at least the most relevant items. These were the
demographic characteristics and the questions on practice patterns
regarding how often sexual counselling took place, as this was the
main outcome. Data concerning fertility issues were processed
separately.
Reliability
Two questions with 5 Likert scales on the subject, how often do
nurses address sexual health with new patients compared to
follow-up settings, had a Cronbach's alpha of 0.80. Scores on reli-
ability of two questions with 5 Likert scales regarding nurses
knowledge about SF also demonstrated good internal consistency
(Cronbach's a ¼ 0.80). The Cronbach's a scores for the subscales on
matching barriers ranged from 0.61 to 0.91, respectively, with 2e3
barriers in every corresponding dimension and 5 Likert scales per
item. Items corresponded as far as cultural/religious/ethnical and
language barriers were concerned, knowledge and complexity,
barriers addressing embarrassment and barriers to raising the
topic.
Survey administration
The questionnaire was available as a web-based and a paper
version. The web-based version was promoted on several online
Dutch oncology nursing platforms, including that of the Dutch
Oncology Nursing Society, relevant social media groups and the
website, www.nursing.nl. The link was e-mailed to all available
addresses of hospitals and oncology nursing departments
throughout The Netherlands with the request to distribute this
amongst employed oncology nurses. Web-based data were
collected from September 2012 to December 2012. The paper
versionwas handed out during the annual Dutch Oncology Nursing
Congress held in Ede on 27e28 November 2012 and delegates (with
the exception of those nurses who had already participated via the
Web) were asked to complete the questionnaire before leaving the
congress. Recruiters at the Congress approached nurses in order to
obtain informed consent. Nurses who had already participated via
theWeb did not receive a copy. Each nurse who participated during
the Congress received a book on cancer and sexuality. Data from the
web-based survey and the congress survey were processed
together. The ten responses from the pilot survey were added to the
final analysis group, since these nurses completed all answers and
only small modifications had been made.
Statistical methods
Data analysis was performed using SPSS (Release 20.0; SPSS
Inc.). The internal consistency of the questionnaire was measured
using Cronbach's coefficient a. The results were described using
frequency distribution. Observed differences between de-
mographic information and specific answers were identified using
the Pearson's chi-square test; McNemar's test was applied forPlease cite this article in press as: Krouwel, E.M., et al., Addressing chan
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tion from congress respondents and web-based respondents was
performed with the Student's t-test and Pearson's chi-square test.
P-values < 0.05 were considered statistically significant.
Ethical considerations
In The Netherlands, research that does not involve patients or
interventions, is not subject to approval from ethical boards. In
previous research where nurses were the participants, the Medical
Ethics Committee was consulted in order to verify whether ethical
approval was necessary. As the study did not concern any infor-
mation recorded by the investigator in such a manner that subjects
could be identified, directly or through identifiers linked to the
subjects, and as it did not compromise the study participants’
integrity, the Committee declared that no formal ethical approval
was needed (Bekker et al., 2011). However, ethical principles were
taken into consideration. With regard to the principle of autonomy,
participation in the survey was completely voluntary. Information
was provided about the study aims and highlighted the anonymous
nature of the survey. Each respondent had to state approval before
participating and an opt-out possibility was implemented. The
principle of justice, beneficence and non-maleficence are not
applicable, since the survey does not involve an actual intervention.




The sample consisted of Dutch nurses involved with cancer
patients working on various departments in several clinical set-
tings, as defined in Fig. 1 and Table 1. A total of 431 nurses
completed the survey and were included in this study. A further 46
questionnaires were completed as far as the most relevant items
were concerned; these were also included. All other incomplete
forms were excluded from analysis; note that these incomplete
forms were submitted by the group using the web-based version.
128 nurses (26.8%) were recruited during the congress, 339 ques-
tionnaires (71.1%) were collected via the website, 10 nurses (2.1%)
were included from the LUMC pilot, making a total of 477 eligible
respondents. For accurate information about study design, re-
spondents and reasons for refusal, see the study flow chart dis-
played in Fig. 2.
Participant characteristics
Demographics from the congress and the online data sets were
compared; no significant differences were found concerning age
(p ¼ 0.73), gender (p ¼ 0.23), type of hospital (p ¼ 0.31), function
(p ¼ 0.27) or experience (p ¼ 0.66). Small differences were seen
regarding areas of expertise (classified by tumour site), as slightly
more nurses recruited during the congress had expertise in hae-
matology (46% versus 33%; p ¼ 0.01), nephrology and urology (41%
versus 31%; p ¼ 0.03), gynaecology (47% versus 37%; p ¼ 0.04) and
head and neck oncology (28% versus 19%; p ¼ 0.04). There was no
significant difference in distribution of other areas of expertise
among the respondents (p ranged from 0.07 to 0.41).
All participants were oncology nurses, a considerable number of
whomhad a degree (22.9%). Themajority of the nurses were female
(90.8%), their ages ranging from 19 to 62 years (median¼ 44 years).
The demographic details are outlined in Table 1. See Fig. 1 for the
distribution over areas of expertise in oncology.ged sexual functioning in cancer patients: A cross-sectional survey
015), http://dx.doi.org/10.1016/j.ejon.2015.05.005
Fig. 1. Distribution of nurses in relation to the areas of expertise, classified by tumour site (n¼ 459).a
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Participants believed that, in general, 69.7% (SE 1.4) of cancer
patients experience some kind of altered SF due to disease and/or
treatment (n ¼ 265). The oncology nurses were asked whether or
not they routinely asked about SF and how often they thought theTable 1
Demographic characteristics of participating nurses.
Demographic characteristics (n ¼ 477) n (%)
Age (years) 460 (96.4)















Registered nursea 84 (17.6)
Registered nurse currently in Oncology registration training 22 (4.6)
Registered nurse with Oncology certificateb 215 (45.1)
Clinical setting
 Inpatient 92 (19.3)
 Outpatient 105 (22)
 In/out-patient 18 (3.8)
Registered nurse with graduate degreec 109 (22.9)
Nurse in charge of Oncology departmentd 10 (2.1)
Research nurse 7 (1.5)
District nurse with Oncology specialisme 8 (1.6)
Different/unknown 22 (4.6)
Hospital type
University hospital 163 (34.2)
District general teaching hospital 141 (29.6)
District general hospital 149 (31.2)
Extramural 8 (1.6)
Unknown 16 (3.4)
a Involved vocational trained nurses as well as bachelor's degree nurses with no
registered specialism but currently employed in an oncology department.
b Involved nurses with official Oncology registration (acknowledged by the Dutch
board of Hospital Education) following 1 year official Oncology training.
c Involved nurses with a graduate degree from a University of Professional Edu-
cation or a University of Science, usually involved with in- and outpatient
departments.
d Clinical setting undefined.
e Involved nurses caring for cancer patients at home.
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explored. Regarding the question ‘How often do you discuss SF?’
nurses indicated the following statistics: never/rarely: 18.9%; in less
than half of the cases: 32.6%; in half of the cases: 15.1%; in more
than half of the cases: 13.4%; and often/always: 20%. Oncology
nurses >44 years discussed SF significantly more often than nurses
44 years (Pearson Chi-Square, p ¼ 0.009). Graduate oncology
nurses discussed SF significantly more frequently compared to the
other nurses (Pearson Chi-Square, p < 0.001). Moreover, experi-
enced nurses (>10 years in oncology practice) discussed SF signif-
icantly more often than less experienced nurses (Pearson Chi-
Square, p ¼ 0.001). An equally strong correlation was found be-
tween level of knowledge and discussing SF (Fig. 3). Nurses with
the self-scored knowledge levels ‘not any’, ‘not somuch’ and ‘some’,
discussed SF less often than nurses with ‘sufficient’ and ‘a lot’ of
knowledge (Pearson Chi-Square, p < 0.001). Seventy-four percent
of the nurses estimated that the oncologist never, rarely or in less
than half of the cases discussed SF with the patients. Further data
about practice attitudes regarding SF are featured in Table 2.
Depending on the type of treatment, significant differences
were observed in percentage of nurses discussing SF: treatment
with intent to cure, 83.2% (n ¼ 396); life-prolonging treatment,
57.1% (n ¼ 272); and palliative treatment 44.5% (n ¼ 212) (McNe-
mar's test p < 0.001). With regard to age, results show that
oncology nurses never/rarely discuss SF with patients aged 66e75
years (60.8%, n ¼ 472) or those over 76 years (73.1%, n ¼ 465). For
younger patients, a majority of the oncology nurses said they dis-
cussed SF regularly/often: in 60% of patients aged 16e35 years
(n ¼ 467), 63.1% of those aged 36e50 years (n ¼ 470) and 57.2% of
the 51e65-year age group (n ¼ 473).Responsibility
The majority of oncology nurses (87.6%) agreed that the
oncology nurse is responsible for discussing SF as far as disease-
related and treatment-related problems were concerned. An
almost equal majority (88.7%) stated that the oncologist also bears
responsibility for discussing SF. On the other hand, 42% of the
nurses considered it to be the patient's responsibility to raise their
sexual concerns during a consultation (n ¼ 469).Availability of local policy or agreement
55.4% of the respondents noted that a local policy or agreement
was in place for discussing SF as standard routine. Approximately aged sexual functioning in cancer patients: A cross-sectional survey
015), http://dx.doi.org/10.1016/j.ejon.2015.05.005
Fig. 2. Study flow diagram showing study design and respondents/non-respondents.
Fig. 3. Level of knowledge about sexual dysfunction following cancer in relation to the frequency of discussing sexual function (p< 0.001 Pearson Chi-Square, n¼ 458).
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Table 2
Frequency distributions on questions in relation to discussing sexual function.







n (%) n (%) n (%) n (%) n (%)
Do you discuss sexual function of the patient 90 (18.9) 155 (32.6) 72 (15.1) 64 (13.4) 95 (20)
Do you think that sexual function is discussed with the oncologist 144 (30.2) 211 (44.2) 73 (15.3) 37 (7.8) 12 (2.5)
Patients present sexual function complaints spontaneously 261 (56.4) 170 (36.7) 19 (4.1) 8 (1.7) 5 (1.1)
Do you make sure that sexual function is discussed with a new patient 109 (23.7) 110 (23.9) 56 (12.2) 77 (16.7) 108 (23.5)
Do you discuss sexual function during check-up appointments 187 (43.1) 120 (27.6) 48 (11.1) 38 (8.8) 41 (9.4)
Is the partner of the patient present during sexual function conversation 55 (12.6) 101 (23.1) 75 (17.2) 107 (24.5) 98 (22.5)
Do you ask about the sexual orientation of the patient 297 (68.1) 55 (12.6) 16 (3.7) 25 (5.7) 43 (9.9)
Do you discuss contagiousness of cancer with the patient 250 (59.5) 65 (15.5) 22 (5.2) 33 (7.9) 50 (11.9)
Do you discuss transmitting chemo agents during intercourse 110 (26.1) 51 (12.1) 39 (9.2) 58 (13.7) 164 (38.9)
E.M. Krouwel et al. / European Journal of Oncology Nursing xxx (2015) 1e96third of the nurses (29%) stated there was no such agreement or
policy in place and 15.6% reported that they did not know if their
department had such a policy. According to 31.3% of the nurses, it
was policy to inform patients about treatment-related sexuality
issues. Only 24.1% of the nurses reported that the department
policy stated that sexuality should be discussed throughout treat-
ment (n ¼ 469). Nurses in such a department discussed SF with
their patients significantly more frequently (Pearson Chi-Square,
p < 0.001). The majority of respondents (85.8%) stated that SF is
not discussed in a multidisciplinary consultation (n ¼ 416).
Knowledge and training
Regarding knowledge levels, a majority stated they had ‘some
knowledge’ or ‘sufficient knowledge’ about SD related to oncolog-
ical illness (41.7% vs. 38.2%). An almost equal number of nurses
stated they had ‘some knowledge’ or ‘sufficient knowledge’ about
treatment-related SD (38.9% vs. 42.5%). However, in response to the
questions concerning solutions for SD, 47.9% reported having ‘some
knowledge’, 24.8% reported having ‘not so much knowledge’
(n ¼ 459). In answer to the question ‘Would you like to acquire
more knowledge on how to address sexual issues?’ 76.3% replied
positively (n ¼ 422). 63% of the nurses stated that current oncology
training does not sufficiently cover the assessment of SF (n ¼ 400).
Techniques for discussing SF
With a view to broaching the subject of SF, 71.3% of the nurses
stated they only addressed the issue of possible sexual side-effects
and 43.3% stated they only informed the patient rather than
questioning him/her. A further 40.5% stated they only discussed SF
if the patient mentioned the subject (n ¼ 443). A small group re-
ported using humour (20.5%). More than half of the nurses
(n ¼ 438) enquired about fatigue (65.1% in female, 59.8% in male)
and insecurity due to altered self-image (56.4% in female, 42.3% in
male). Less than a third of the nurses asked their female patients if
vaginal dryness was a problem (28.5%), but 51.7% of the nurses
asked male patients about erectile dysfunction. We also asked
about the availability of written information for patients. Over half
of the nurses stated that such information is not available in their
department (56%, n ¼ 441).
Barriers
The oncology nurses were given a list of possible barriers to
discussing SF, in order for them to indicate the extent to which they
agreed (Table 3). Nurses mentioned ‘lack of training’ as a major
barrier (42%). The second barrier, with which 41.2% of the nurses
agreed, was ‘presence of a third party’. Other barriers, withPlease cite this article in press as: Krouwel, E.M., et al., Addressing chan
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motive for asking’ (32%), ‘advanced age of the patient’ (30.8%) and
‘language/ethnicity’ (30.3%). The least consensus was reached on
the barriers: ‘colleagues think it is inappropriate if I discuss SF with
patients’ (1.1%) and ‘patient is the same gender’ (1.4%).
Importance
The importance of assessing SF in oncology patients was
addressed at the end of the questionnaire (n ¼ 414). A majority of
the nurses (56%) considered the need to assess SF as ‘important’; an
additional number stated it was ‘very important’ (13.8%). The
remaining respondents indicated it was ‘important to some extent’
(27.1%), ‘not very important’ (2.4%) or ‘unimportant’ (0.7%). Ac-
cording to the responding oncology nurses, patients with whom SF
should be discussed hardly bears any relation to the tumour site
(Table 4). Most nurses thought SF should definitely be discussed
with breast cancer patients (95.7%) and gynaecological cancer pa-
tients (94.0%). By contrast, according to 2.6% of the nurses, it was
not necessary to discuss SF. For a complete summary of the patients




This survey provides extensive data on routine practice
regarding sexual health issues in a nationwide sample of Dutch
oncology nurses. It also looks at the level of knowledge about these
issues and the barriers to tackling them. Participating nurses esti-
mated that the majority of cancer patients experience some degree
of SD. Generally, a third of the oncology nurses enquire routinely
about SF, depending on the patient's age and type of treatment
(curative vs. life-prolonging vs. palliative treatment). When ques-
tioned further, the nurses who did discuss SF stated they only
addressed possible sexual side-effects or informed the patient
rather than discussing the sexual concerns. Despite these practice
patterns, a majority believed it was their responsibility, as well as
that of the oncologist, to provide SF counselling. The strongest
barriers to discussing SF found in this study were lack of training,
presence of a third party, no angle or motive for asking, advanced
age of the patient and different language/ethnicity.
Comparison with other population data
The findings support and extend previous research in western
countries concerning reasonswhy oncology nurses do not routinely
discuss matters of sexuality with cancer patients. Besides routineged sexual functioning in cancer patients: A cross-sectional survey
015), http://dx.doi.org/10.1016/j.ejon.2015.05.005
Table 3
Frequency analysis on barriers in relationship to discussing sexual function.
Items: Barriers in discussing sexual functiona Totally agree Agree Partly agree/partly disagree Disagree Totally disagree
n (%) n (%) n (%) n (%) n (%)
Lack of training 32 (7.5) 148 (34.5) 123 (28.7) 93 (21.7) 33 (7.7)
Presence of a third party 22 (5.2) 153 (36) 121 (28.5) 103 (24.2) 26 (6.1)
No angle or motive for asking 15 (3.5) 121 (28.5) 126 (29.7) 109 (25.7) 53 (12.5)
Advanced age of the patient 15 (3.5) 117 (27.3) 127 (29.6) 124 (28.9) 46 (10.7)
Language/ethnicity 13 (3) 117 (27.3) 156 (36.4) 118 (27.5) 25 (5.8)
Culture/religion 8 (1.9) 117 (27.3) 159 (37.1) 116 (27) 29 (6.8)
Patient is too ill 17 (4.0) 105 (24.4) 134 (31.2) 130 (30.2) 44 (10.2)
Lack of knowledge 20 (4.7) 87 (20.3) 136 (31.7) 141 (32.9) 45 (10.5)
Patient doesn’t bring up the subject 9 (2.1) 90 (21.1) 104 (24.4) 156 (36.6) 67 (15.7)
High complexity of sexual disorder 6 (1.4) 89 (21) 139 (32.9) 144 (34) 45 (10.6)
I feel uncomfortable 12 (2.8) 71 (16.7) 108 (25.4) 162 (38.1) 72 (16.9)
Patient is not ready to discuss sexual function 10 (2.3) 72 (16.7) 142 (33) 145 (33.7) 61 (14.2)
Lack of time 17 (4) 58 (13.5) 81 (18.9) 156 (36.4) 117 (27.3)
Sexuality is a private matter 4 (0.9) 67 (15.7) 134 (31.5) 160 (37.6) 61 (14.3)
Embarrassment 1 (0.2) 65 (15.3) 99 (23.3) 188 (44.2) 72 (16.9)
Concerned about making patient uncomfortable 0 (0) 52 (12.1) 113 (26.3) 192 (44.5) 73 (17)
Sexuality is not a patient’s concern 3 (0.7) 48 (11.2) 128 (29.8) 173 (40.2) 78 (18.1)
Age difference between you and patient 5 (1.2) 45 (10.5) 62 (14.5) 226 (52.7) 91 (21.2)
Surviving is more important 4 (0.9) 45 (10.6) 130 (30.6) 168 (39.5) 78 (18.4)
Not relevant for all type of cancers 3 (0.7) 35 (8.3) 69 (16.3) 213 (50.2) 104 (24.5)
Afraid to offend the patient 1 (0.2) 37 (8.7) 99 (23.3) 212 (49.9) 76 (17.9)
Sexuality is not a matter of life and death 1 (0.2) 19 (4.5) 89 (20.9) 229 (53.9) 87 (20.5)
It’s someone else’s task 1 (0.2) 14 (3.3) 52 (12.1) 190 (44.3) 172 (40.1)
No confidence in treatment for sexual dysfunction 0 (0) 14 (3.3) 86 (20.2) 230 (54.1) 95 (22.4)
Patient is the opposite gender 0 (0) 13 (3.1) 40 (9.4) 230 (54) 143 (33.6)
Patient is the same gender 2 (0.5) 4 (0.9) 22 (5.1) 259 (60.4) 142 (33.1)
Colleagues think it’s inappropriate if I discuss sexual function with patients 1 (0.2) 4 (0.9) 31 (7.3) 222 (52.0) 169 (39.6)
a Barriers sorted descending from most agreed (totally agree þ agree) to least agreed (disagree þ totally disagree).
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of sexual counselling, which help to interpret the data. Previous
studies had less-representative samples; they were small, based on
a single-centre, unequal in age distribution, or included other
health care workers in the sample (Kotronoulas et al., 2009). The
present study describes a high rate of acceptance that SF consul-
tation should be both the nurses’ (87.6%) and the physicians’
(88.7%) responsibility compared to earlier studies, in which nurses
stated that addressing SF was not included in their task, with
62.5%e78% regarding it as being their responsibility (Hautamaki
et al., 2007; Nakopoulou et al., 2009; Saunamaki et al., 2010). This
finding might be the result of a growing awareness of the sexual
burden in cancer patients within the last 20 years. However, theTable 4
Patients with who sexual function should be discussed according to respondents (n
¼ 416).
Type of patients Nurses agreeing sexual
function should be discussed
with these patients
n (%)
Breast cancer 398 (95.7)
Gynaecological cancer 391 (94.0)
Urological cancer 368 (88.5)
Colorectal cancer 366 (88.0)
Haematological cancer 295 (70.9)
Head/neck cancer 293 (70.4)
Lung cancer 280 (67.3)
Nephrological cancer 277 (66.6)
Lymphoma 270 (64.9)
Palliative cancer care 262 (63.0)
Neuro-endocrine cancer 257 (61.8)
Sarcoma 255 (61.4)
Skin cancer 254 (61.1)
I do not believe it is necessary
to discuss sexual function
11 (2.6)
Please cite this article in press as: Krouwel, E.M., et al., Addressing chan
among Dutch oncology nurses, European Journal of Oncology Nursing (2level of knowledge concerning SF remains unsatisfactory. We found
a similar frequency of discussing SF as a recent study from Finland,
in which a third of the oncology nurses stated they discussed SF
fairly frequently, also influenced by work experience. Their cut-off
point was, however, 2 years whereas ours was 10 years
(Hautamaki et al., 2007). Factors influencing the provision of sexual
counselling correspond to a previous study from The Netherlands,
indicating that little has changed. Age, experience and knowledge
also correlated positively with routinely addressing SF (Gamel et al.,
1995). Julien et al. described that nurses aged younger than 40 years
reported more barriers than older nurses. This is similar to our
finding regarding nurses’ age influencing incidence of discussing SF.
In contrast to our data, in this sample, the level of educationwas not
correlated with the barriers experienced in relation to sexual
counselling (Julien et al., 2010). The main barrier, ‘lack of training’,
matched other studies, where lack of training and lack of knowl-
edge were given as the main reasons for not assessing SF. This
supports our finding that adequate training is one of the main
determining factors (Bekker et al., 2011; Gamel et al., 1995;
Hautamaki et al., 2007; Nicolai et al., 2013). Contrary to findings
in a Chinese oncology nursing study, time and ‘sexuality is a private
matter’ are hardly mentioned as barriers in western studies (Zeng
et al., 2011). It is helpful to realize that time is not a barrier for
discussing SF, despite the current cost reductions which may result
in an increased burden for health care providers.
Sexual counselling
The present study reveals an apparent incongruity between
treatment objectives and their implementation. Despite the fact it
was relatively rare for nurses to take the initiative in discussing
sexuality-related issues, themajority acknowledged that it is part of
their job and also the responsibility of the oncologist. Not every
patient needs extensive discussion about sexual issues. We do,
however, believe that as a part of informed consent for severalged sexual functioning in cancer patients: A cross-sectional survey
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some point. Furthermore, if the subject is simply addressed once,
the patient can then decide themselves to bring it up again. The
challenge is for the nurse to raise the subject, and if the patient
expresses interest in discussing it, to do so. The strong association
between the frequency of discussing SF and nursing experience,
specialization and self-reported knowledge, supports the evident
need for expanding educational activities. This is reinforced by a
majority of the nurses stating they would like to acquire more
knowledge, specifically about possible solutions for cancer-related
SD. This survey did not take into account whether nurses had
received any education on handling sexual issues in the past, an
aspect which could be interesting in future survey research. During
training, we recommend that the importance of discussing SF with
cancer patients be highlighted, not only with the obviously affected
patient (i.e. breast-, gynaecological-, urological- and colorectal
patients). SF is also affected in other cancers, as it can deteriorate
due to many causes including relationship issues, fatigue and
changed appearance as a result of surgery or chemotherapy. Most
nurses in this survey seemed aware that SF is of great importance in
all forms of cancer; fewer believed that SF should be discussed with
cancers not involving the breast, intestines or genitals. Lemieux
et al. showed the importance of addressing SF even in a palliative
treatment setting which unfortunately, according to our study,
hardly ever happens, with a special role for the district nurse
(Lemieux et al., 2004). Furthermore, a very important component is
the presence of a local policy or agreement regarding initiating
discussions on SF as a matter of routine. This study exposed the
clear relationship between the availability of such a policy and the
actual frequency of mentioning SF in a consultation. The consid-
erable lack of availability and lack of awareness of local agreement
on sexual counselling as a matter of routine should be a significant
point of interest for heads of nursing departments.
Clearly, not every nurse should be forced into the role of sexual
counsellor, since not everyone is able to discuss this controversial
subject, for example because of private circumstances such as a bad
sexual experience or religion. For this reason, considerable benefit
could be derived by implementing a clinical nurse specialist on
quality of life and sexuality, as investigated for gynaecological
oncology purposes with successful results (Maughan and Clarke,
2001). Further research should investigate (1) the role other
oncology health care providers could play in sexual counselling, (2)
who could act as the coordinating staff member and (3) how to
implement solutions beneficial to the unmet need for information.
Study limitations and strengths
Possible limitations of this study demand some reflection. The
results presented are of self-reported attitudes and those nurses
who responded are more likely to be those already familiar with
addressing sexual health issues. Efforts were made to ensure a
more neutral response group by securing the anonymous nature of
the survey, convincing nurses of the importance of this survey and
providing a reward in the form of books in exchange for partici-
pation as an incentive to motivate less-concerned nurses.
The administered questionnaire was non-validated, since vali-
dated instruments like the SABS did not incorporate the main ob-
jectives and additional study aims (Reynolds andMagnan, 2005). In
epidemiology, it is a well-known fact that re-using standard
questionnaires will not necessarily point towards the exposure of
interest, especially not when translated from another language
(Silman and MacFarlane, 2002). However, all topics of the SABS
were included and attempts were made to test for validity and
reliability. The internal consistencies of themost important items of
the questionnaire tested as acceptable to excellent. Test-retestPlease cite this article in press as: Krouwel, E.M., et al., Addressing chan
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impossible due to the anonymous pilot design and study design.
Cultural, religious and partnership status of respondents were
excluded in response to the pilot panel's decision; they felt they
might have made the questionnaire too sensitive. Demographic
particulars of the nurses indicated a heterogeneous sample
regarding age and experience, although not for gender, since the
majority were female. Comparison between the congress re-
spondents and web-based respondents resulted in minor de-
mographic differences regarding area of expertise; all other
demographics were comparable. The Dutch Oncology Nursing So-
ciety currently has approximately 2400 members; hence the sam-
ple of 477 respondents in our survey is deemed sufficiently
representative of the Dutch oncology nursing population (Bartlett
et al., 2001). This is reinforced by the fact that the congress sam-
ple and the web-based sample were almost similar, suggesting our
sample is a credible reflection of the total oncology nursing pop-
ulation. Finally, it was not possible to calculate the actual response
rate, due to the combination of manual provision of questionnaires
and the anonymous web-based design. The web-based survey
revealed a high number of incomplete forms. Explanations for the
high incompletion rate are technical website issues and the anon-
ymous web-based form which could not be continued at a later
stage if time was short. Nor was it possible to estimate the extent of
a non-response or a sampling bias. However, the interpretation of
the response rate in general is questionable, since even a high
response rate does not obviate a non-response bias (Barclay et al.,
2002).Conclusion
Overall, the present study revealed that oncology nurses
consider counselling on sexual issues to be an important re-
sponsibility, in line with discussing other side-effects caused by the
disease or its treatment. Nevertheless, findings suggest that cancer
patients may not routinely be receiving a sexual health evaluation
by oncology nurses. While taking sexual histories on a routine basis
is believed to enhance the quality of life, oncology nurses believed
that oncologists address the subject rarely. The strongest barriers to
discussing SF were lack of training, presence of a third party, no
angle or motive for asking, advanced age of the patient and
different language/ethnicity. Sexual counselling is provided signif-
icantly more often by nurses who have undergone further training,
are more experienced, older, possess an academic degree and work
in a department with a strict policy concerning SF. This emphasizes
the potential effect of providing adequate knowledge and appro-
priate practice training. Policies and patient information regarding
SF should be available in all nursing care units.Implications for oncology nursing practice
We sincerely hope that this study has emphasized the impor-
tance of discussing SD with all cancer patients and that the evi-
dence presented will encourage nurses to address this often
overlooked issue, thereby moving a step closer towards improving
the quality of life of cancer patients. Oncological health care pro-
viders should agree on when and to which extent SF should be
discussed, and in particular by whom.Conflicts of interest
There are no conflicts of interest to disclose.ged sexual functioning in cancer patients: A cross-sectional survey
015), http://dx.doi.org/10.1016/j.ejon.2015.05.005
E.M. Krouwel et al. / European Journal of Oncology Nursing xxx (2015) 1e9 9Funding Source
This study was initiated by the Pelvic Floor and Sexuality
Research Group Leiden. The study was supported by the Target
Fund Urology of the Leiden University Medical Centre Bontius
Foundation and an unrestricted grant from AstraZeneca.
Acknowledgements
First of all, we are very grateful to the many nurses who
voluntarily participated in our survey. We would also like to thank
Caroline de Jong-Mom and Liza Lima Setyawan for their assistance
in collecting and importing the data. Linguistic supervision was
performed by Mrs. Brenda Vollers-King.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.ejon.2015.05.005.
References
Ananth, H., Jones, L., King, M., Tookman, A., 2003. The impact of cancer on sexual
function: a controlled study. Palliative Medicine 2, 202e205.
Baker, F., Denniston, M., Smith, T., West, M.M., 2005. Adult cancer survivors: how
are they faring? Cancer 11 (Suppl. l), 2565e2576. http://dx.doi.org/10.1002/
cncr.21488.
Barclay, S., Todd, C., Finlay, I., Grande, G., Wyatt, P., 2002. Not another questionnaire!
Maximizing the response rate, predicting non-response and assessing non-
response bias in postal questionnaire studies of GPs. Family Practice 1, 105e111.
Bartlett, J.E., Kotrlik, J.W., Higgins, C.C., 2001. Organizational research: determining
appropriate sample size in survey research. Information Technology, Learning
and Performance Journal 19, 43e50.
Beckjord, E.B., Arora, N.K., Bellizzi, K., Hamilton, A.S., Rowland, J.H., 2011. Sexual
well-being among survivors of non-Hodgkin lymphoma. Oncology Nursing
Forum 5, E351eE359. http://dx.doi.org/10.1188/11.ONF.E351-E359.
Bekker, M., Beck, J., Putter, H., van, D.M., Pelger, R., Lycklama, A.N., et al., 2009. The
place of female sexual dysfunction in the urological practice: results of a Dutch
survey. Journal of Sexual Medicine 11, 2979e2987. http://dx.doi.org/10.1111/
j.1743-6109.2009.01460.x.
Bekker, M.D., Van Driel, M.F., Pelger, R.C., Nijeholt, G.A., Elzevier, H.W., 2011. How do
continence nurses address sexual function and a history of sexual abuse in daily
practice? Results of a pilot study. Journal of Sexual Medicine 2, 367e375. http://
dx.doi.org/10.1111/j.1743-6109.2010.02044.x.
Den Oudsten, B.L., Traa, M.J., Thong, M.S., Martijn, H., De Hingh, I.H., Bosscha, K.,
et al., 2012. Higher prevalence of sexual dysfunction in colon and rectal cancer
survivors compared with the normative population: a population-based study.
European Journal of Cancer 17, 3161e3170. http://dx.doi.org/10.1016/
j.ejca.2012.04.004.
Flynn, K.E., Jeffery, D.D., Keefe, F.J., Porter, L.S., Shelby, R.A., Fawzy, M.R., et al., 2011.
Sexual functioning along the cancer continuum: focus group results from the
Patient-Reported Outcomes Measurement Information System (PROMIS(R)).
Psychooncology 4, 378e386. http://dx.doi.org/10.1002/pon.1738.
Flynn, K.E., Reese, J.B., Jeffery, D.D., Abernethy, A.P., Lin, L., Shelby, R.A., et al., 2012.
Patient experiences with communication about sex during and after treatment
for cancer. Psychooncology 6, 594e601. http://dx.doi.org/10.1002/pon.1947.
Galbraith, M.E., Crighton, F., 2008. Alterations of sexual function in menwith cancer.
Seminars in Oncology Nursing 2, 102e114. http://dx.doi.org/10.1016/
j.soncn.2008.02.010.
Gamel, C., Hengeveld, M.W., Davis, B., van der Tweel, I., 1995. Factors that influence
the provision of sexual health care by Dutch cancer nurses. International
Journal of Nursing Studies 3, 301e314.
Hautamaki, K., Miettinen, M., Kellokumpu-Lehtinen, P.L., Aalto, P., Lehto, J., 2007.
Opening communication with cancer patients about sexuality-related issues.
Cancer Nursing 5, 399e404. http://dx.doi.org/10.1097/
01.NCC.0000290808.84076.97.
Hill, E.K., Sandbo, S., Abramsohn, E., Makelarski, J., Wroblewski, K., Wenrich, E.R.,
et al., 2011. Assessing gynecologic and breast cancer survivors’ sexual health
care needs. Cancer 12, 2643e2651. http://dx.doi.org/10.1002/cncr.25832.Please cite this article in press as: Krouwel, E.M., et al., Addressing chan
among Dutch oncology nurses, European Journal of Oncology Nursing (2Hordern, A., Street, A., 2007. Issues of intimacy and sexuality in the face of cancer:
the patient perspective. Cancer Nursing 6, E11eE18. http://dx.doi.org/10.1097/
01.NCC.0000300162.13639.f5.
Hughes, M.K., 2008. Alterations of sexual function in women with cancer. Seminars
in Oncology Nursing 2, 91e101. http://dx.doi.org/10.1016/j.soncn.2008.02.003.
Integraal Kankercentrum Nederland, 2006. Richtlijn Veranderd seksueel functio-
neren, Versie 1.1. IKNL (NL), Comprehensive Cancer Centre the Netherlands,
Utrecht.
Julien, J.O., Thom, B., Kline, N.E., 2010. Identification of barriers to sexual health
assessment in oncology nursing practice. Oncology Nursing Forum 3,
E186eE190. http://dx.doi.org/10.1188/10.ONF.E186-E190.
Kotronoulas, G., Papadopoulou, C., Patiraki, E., 2009. Nurses’ knowledge, attitudes,
and practices regarding provision of sexual health care in patients with cancer:
critical review of the evidence. Supportive Care in Cancer 5, 479e501. http://
dx.doi.org/10.1007/s00520-008-0563-5.
Krebs, L.U., 2008. Sexual assessment in cancer care: concepts, methods, and stra-
tegies for success. Seminars in Oncology Nursing 2, 80e90. http://dx.doi.org/
10.1016/j.soncn.2008.02.002.
Lange, M.M., Marijnen, C.A., Maas, C.P., Putter, H., Rutten, H.J., Stiggelbout, A.M.,
et al., 2009. Risk factors for sexual dysfunction after rectal cancer treatment.
European Journal of Cancer 9, 1578e1588. http://dx.doi.org/10.1016/
j.ejca.2008.12.014.
Lavin, M., Hyde, A., 2006. Sexuality as an aspect of nursing care for women receiving
chemotherapy for breast cancer in an Irish context. European Journal of
Oncology Nursing 1, 10e18. http://dx.doi.org/10.1016/j.ejon.2005.03.013.
Lemieux, L., Kaiser, S., Pereira, J., Meadows, L.M., 2004. Sexuality in palliative care:
patient perspectives. Palliative Medicine 7, 630e637.
Maughan, K., Clarke, C., 2001. The effect of a clinical nurse specialist in gynaeco-
logical oncology on quality of life and sexuality. Journal of Clinical Nursing 2,
221e229.
Nakopoulou, E., Papaharitou, S., Hatzichristou, D., 2009. Patients’ sexual health: a
qualitative research approach on Greek nurses’ perceptions. Journal of Sexual
Medicine 8, 2124e2132. http://dx.doi.org/10.1111/j.1743-6109.2009.01334.x.
Nicolai, M.P., Both, S., Liem, S.S., Pelger, R.C., Putter, H., Schalij, M.J., et al., 2013.
Discussing sexual function in the cardiology practice. Clinical Research in Car-
diology. http://dx.doi.org/10.1007/s00392-013-0549-2.
Olsson, C., Berglund, A.L., Larsson, M., Athlin, E., 2012. Patient's sexuality e a
neglected area of cancer nursing? European Journal of Oncology Nursing 4,
426e431. http://dx.doi.org/10.1016/j.ejon.2011.10.003.
Oskay, U., Can, G., Basgol, S., 2014. Discussing sexuality with cancer patients:
oncology nurses attitudes and views. Asian Pacific Journal of Cancer Prevention
17, 7321e7326.
Reynolds, K.E., Magnan, M.A., 2005. Nursing attitudes and beliefs toward human
sexuality: collaborative research promoting evidence-based practice. Clinical
Nurse Specialist 5, 255e259.
Sadovsky, R., Basson, R., Krychman, M., Morales, A.M., Schover, L., Wang, R., et al.,
2010. Cancer and sexual problems. Journal of Sexual Medicine 1 (2), 349e373.
http://dx.doi.org/10.1111/j.1743-6109.2009.01620.x.
Saunamaki, N., Andersson, M., Engstrom, M., 2010. Discussing sexuality with pa-
tients: nurses’ attitudes and beliefs. Journal of Advanced Nursing 6, 1308e1316.
http://dx.doi.org/10.1111/j.1365-2648.2010.05260.x.
Silman, A.J., MacFarlane, G.J., 2002. Epidemiological Studies. A Practical Guide,
second ed. Cambridge University Press, Cambridge.
Stead, M.L., Brown, J.M., Fallowfield, L., Selby, P., 2003. Lack of communication be-
tween healthcare professionals and women with ovarian cancer about sexual
issues. British Journal of Cancer 5, 666e671. http://dx.doi.org/10.1038/
sj.bjc.6600799.
Valencius, J.C., Packard, R., Widiss, T., 1980. The ONS-ANA outcome standards for
cancer nursing practice: two models for implementation. II. Implementation of
the nutrition standard at City of Hope National Medical Center. Oncology
Nursing Forum 3, 37e40.
White, I.D., Allan, H., Faithfull, S., 2011. Assessment of treatment-induced female
sexual morbidity in oncology: is this a part of routine medical follow-up after
radical pelvic radiotherapy? British Journal of Cancer 7, 903e910. http://
dx.doi.org/10.1038/bjc.2011.339.
World Health Organization, 2006. Defining Sexual Health: Report of a Technical
Consultation on Sexual Health, 28e31 January 2002, Geneva. World Health
Organization, Geneva.
Wright, E.P., Kiely, M.A., Lynch, P., Cull, A., Selby, P.J., 2002. Social problems in
oncology. British Journal of Cancer 10, 1099e1104. http://dx.doi.org/10.1038/
sj.bjc.6600642.
Zeng, Y.C., Li, Q., Wang, N., Ching, S.S., Loke, A.Y., 2011. Chinese nurses’ attitudes and
beliefs toward sexuality care in cancer patients. Cancer Nursing 2, E14eE20.
http://dx.doi.org/10.1097/NCC.0b013e3181f04b02.ged sexual functioning in cancer patients: A cross-sectional survey
015), http://dx.doi.org/10.1016/j.ejon.2015.05.005
